Summary
RMC No. 59-2025 publishes the full text of the March 26, 2025 letter from the FDA endorsing updates to the List of VAT-Exempt Products under RA No. 10963 (TRAIN Law) and RA No. 11534 (CREATE Act).
CollapseExpand
Key points
- Updated list. The letter was written by FDA Director General Samuel A. Zacate. The list now includes certain medicines for cancer, diabetes, hypertension, kidney disease, and tuberculosis.
- Effectivity of exemption. The VAT exemption of the medicines on the list takes effect upon the issuance of an FDA Advisory.
Deadlines and effectivity
- VAT exemption effective upon issuance of an FDA Advisory
Summary by Tax Resources PH. It is not a substitute for the full text of the issuance or professional advice.
Copies of BIR issuances are hosted here for reference. For the official version, check bir.gov.ph. Summaries by Tax Resources PH are not a substitute for the full text or professional advice.
